Arch holding strong ahead of trial data.With Trial data coming up the company is set for a bull run but in the meantime it has enough buyer interest to hold with strong support.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.04 CAD
−3.92 M CAD
0.00 CAD
51.17 M
About Arch Biopartners, Inc.
Sector
Industry
CEO
Richard Gabriel Muruve
Website
Headquarters
Toronto
Founded
1983
ISIN
CA03938C1041
FIGI
BBG0086KK366
Arch Biopartners, Inc. is a portfolio-based biotechnology company, which engages in the development of technologies that have the potential to make a significant medical or commercial impact. Its technology platforms include AB569 and Borg: Peptide-Solid Surface Interface. The company was founded by Richard Gabriel Muruve and Daniel Muruve on March 4, 1983 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ARCH is 1.70 CAD — it has decreased by −0.58% in the past 24 hours. Watch Arch Biopartners, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange Arch Biopartners, Inc. stocks are traded under the ticker ARCH.
ARCH stock has risen by 0.59% compared to the previous week, the month change is a 7.59% rise, over the last year Arch Biopartners, Inc. has showed a 18.06% increase.
ARCH reached its all-time high on Dec 1, 2021 with the price of 5.29 CAD, and its all-time low was 0.47 CAD and was reached on Jul 25, 2017. View more price dynamics on ARCH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARCH stock is 3.01% volatile and has beta coefficient of 0.73. Track Arch Biopartners, Inc. stock price on the chart and check out the list of the most volatile stocks — is Arch Biopartners, Inc. there?
Today Arch Biopartners, Inc. has the market capitalization of 109.08 M, it has increased by 2.44% over the last week.
Yes, you can track Arch Biopartners, Inc. financials in yearly and quarterly reports right on TradingView.
Arch Biopartners, Inc. is going to release the next earnings report on Feb 3, 2026. Keep track of upcoming events with our Earnings Calendar.
ARCH earnings for the last quarter are 0.00 CAD per share, whereas the estimation was −0.02 CAD resulting in a 80.00% surprise. The estimated earnings for the next quarter are −0.02 CAD per share. See more details about Arch Biopartners, Inc. earnings.
ARCH net income for the last quarter is −242.33 K CAD, while the quarter before that showed −624.35 K CAD of net income which accounts for 61.19% change. Track more Arch Biopartners, Inc. financial stats to get the full picture.
No, ARCH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARCH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arch Biopartners, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arch Biopartners, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arch Biopartners, Inc. stock shows the sell signal. See more of Arch Biopartners, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.